Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Omnicom Group Inc. (OMC) vs Stryker Corporation (SYK) Price & Performance

Omnicom Group Inc.Trade
Stryker CorporationTrade

Price performance (Past 24H)

Key statistics

Omnicom Group Inc. vs Stryker Corporation — how do they compare? Omnicom Group Inc. trades at $79.2 (market cap $22.58B), while Stryker Corporation trades at $309.5 (market cap $120.60B). The key difference: Stryker Corporation is far larger — about 5.3× Omnicom Group Inc.'s market cap, and Omnicom Group Inc. pays the higher dividend (4.04%). Which is the better fit depends on your goals.

OMCSYK
Market Cap
$22.58B$120.60B
Sector
MediaTechnology
52-Week High
$85.80$403.53
52-Week Low
$67.27$282.58
Enterprise Value
$29.80B$132.36B
Dividend Yield
4.04%1.12%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Omnicom Group Inc.

Omnicom Group (OMC) trades at $79.21, down 3.08% today, with a bullish technical signal from moving averages. The company reported mixed Q1 2026 earnings, beating expectations with $1.90 EPS versus $1.82 expected, but Q4 2025 missed at $2.59 versus $2.72. Revenue growth is strong, reaching $17.27 billion in 2025, though net income was negative $54.50 million due to elevated taxes. Analyst consensus is mixed with 32% buy ratings and a $105.75 price target, representing significant upside. Recent news highlights major client wins including IBM's global media account and partnerships with Netflix and Disney.

OMC presents a value opportunity with a low P/E of 12.16 and P/S of 0.96, trading below analyst targets. The advertising holding company benefits from AI platform expansion and strategic partnerships, but faces margin pressure and intense competition. Near-term catalysts include Q2 2026 earnings on July 28, 2026, where the company must deliver on the expected $2.58 EPS to maintain investor confidence amid current bearish sentiment.

Stryker Corporation

Stryker (SYK) trades at $319.14, down 0.23% with a bearish technical signal despite strong fundamentals. The company reported $25.12B revenue and $3.25B net income for 2025, maintaining robust margins. Recent news highlights Mako RPS launch expansion in robotic surgery, while Q1 2026 earnings missed expectations due to a temporary cyber disruption, though full-year guidance remains unchanged.

Outlook remains positive with 74% analyst buy ratings and a $388.44 consensus price target implying 22% upside. Key risks include competitive pressures and execution challenges from recent cybersecurity issues. The stock presents a growth opportunity in med-tech innovation, trading below historical valuation multiples with healthy cash flow generation.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Omnicom Group Inc.

Omnicom is the world's second- largest ad holding company, based on annual revenue. The firm's services, which include traditional and digital advertising and public relations, are provided worldwide, with over 85% of its revenue coming from more developed regions such as North America and Europe.

Read more on OMC

About Stryker Corporation

Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.

Read more on SYK